Biochemical improvement after treatment by bone marrow transplantation in I-cell disease.
The first case of successful bone marrow transplantation (BMT) in a patient with I-cell disease is reported. A 8-month-old girl with I-cell disease (N-acetylglucosaminylphosphotransferase deficiency) has had successful reconstitution with bone marrow from her HLA-MLC-matched brother who has heterozygous level of the transferase activity. The following biochemical and clinical improvements have occurred: the transferase in peripheral lymphocytes increased to donor's level, and lymphocytic alpha-neuraminidase, beta-galactosidase and alpha-mannosidase increased to normal levels. Plasma acid hydrolase activities, which had been 10 to 60 times higher in the patient than normal control levels, have slowly but steadily decreased from one month after the graft. Such decreases were observed in the activities of alpha-mannosidase, N-acetyl-beta-glucosaminidase, alpha-fucosidase, arylsulfatase A and acidic beta-galactosidase. There was also a marked decrease of vacuolated peripheral lymphocyte after the BMT. Three-months after the engraftment, hepatomegaly gradually decreased in size, corneal clouding has not progressed, and tight skin seems to have improved.
D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D006867:Hydrolases / Q000097:blood; D007223:Infant; D008214:Lymphocytes / Q000201:enzymology / Q000473:pathology; D008361:Mannosidases / Q000097:blood; D009439:Neuraminidase / Q000097:blood; D010770:Phosphotransferases / Q000097:blood / Q000172:deficiency*; D017855:Transferases (Other Substituted Phosphate Groups); D043323:alpha-Mannosidase; D001616:beta-Galactosidase / Q000097:blood
D010770:Phosphotransferases; D017855:Transferases (Other Substituted Phosphate Groups); C030012:UDP-N-acetylglucosamine-lysosomal-enzyme-N-acetylglucosaminephosphotransferase; D006867:Hydrolases; D008361:Mannosidases; D009439:Neuraminidase; D001616:beta-Galactosidase; D043323:alpha-Mannosidase